相关实验视频

Updated: Sep 10, 2025

Analyzing Oxygen Consumption Rate in Primary Cultured Mouse Neonatal Cardiomyocytes Using an Extracellular Flux Analyzer

Analyzing Oxygen Consumption Rate in Primary Cultured Mouse Neonatal Cardiomyocytes Using an Extracellular Flux Analyzer

Published on: February 13, 2019

系统性Lonp1哈普洛因不足通过潜在的器官间交叉声引起的心脏线粒体功能障碍

Sakthijothi Muthu¹, Zinnia Tran¹, Ramasamy Saminathan¹

¹Department of Physiology, Pharmacology and Toxicology, School of Medicine, West Virginia University, Morgantown, WV 26506, USA.

|August 28, 2025

概括

系统调节线粒体质量控制途径可以保护心脏. 这项研究表明全身LONP1缺陷可以防止心脏功能障碍,与心脏特异性缺陷不同,突显了心脏弹性的器官间信号.

科学领域:

线粒体生物学
心血管生理学
分子遗传学

背景情况:

由LONP1调节的线粒体矩阵蛋白质质量控制 (mPQC) 对心脏功能至关重要.
心脏mPQC缺陷可能导致线粒体功能障碍,但通过心脏外组织的缓解尚未探索.

研究的目的:

调查mPQC在非心脏组织中的调节是否可以保护心脏免受功能障碍.
为了比较心肌细胞特异性与全身异构的Lonp1淘汰赛小鼠模型中的心脏结果.

主要方法:

产生和分析心肌细胞特异性 (Lonp1^CKO-HET) 和全身 (Lonp1^GKO-HET) 异构的 Lonp1淘汰小鼠模型.
评估心脏功能,线粒体应激反应标志物 (例如Clpx,Spg7,Hspa9,Hspd1),线粒体动态 (Pink1,Dnm1),生物发生和Tfam表达.

主要成果:

尽管心脏mRNA减少,但GKO-HET小鼠没有表现出心脏功能障碍.
Lonp1^CKO-HET小鼠表现出轻微的心脏功能障碍与激活的线粒体应激反应和改变的线粒体动力学/生物发生.
这些心脏变化在Lonp1^{GKO- HET}小鼠中不存在,表明具有保护性全身效应.

结论:

通过器官间的沟通,mPQC的系统性缺乏可以缓冲心脏线粒体功能障碍.
这种保护信号的丧失发生在心肌细胞特异的mPQC中断时.
系统性LONP1调节提供了一种潜在的策略,通过器官间信号来增强心脏弹性.

关键词:

一个LONP 心脏功能障碍一个心线粒体线粒体功能障碍线粒体矩阵蛋白质质量控制

更多相关视频

A Flow Cytometry-based Assay for Measuring Mitochondrial Membrane Potential in Cardiac Myocytes After Hypoxia/Reoxygenation

A Flow Cytometry-based Assay for Measuring Mitochondrial Membrane Potential in Cardiac Myocytes After Hypoxia/Reoxygenation

Published on: July 13, 2018

Isolation and Physiological Analysis of Mouse Cardiomyocytes

Isolation and Physiological Analysis of Mouse Cardiomyocytes

Published on: September 7, 2014

相关概念视频

Pathophysiology of Heart Failure

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...

Cardiomyopathy V: Interprofessional Care

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...

Cardiomyopathy IV: Restrictive Cardiomyopathy

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...

Cardiomyopathy II: Dilated Cardiomyopathy

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...

Myocarditis I: Introduction

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...